0
August 27, 2008, Vol 300, No. 8 >

Full Content is available to subscribers

Subscribe/Learn More
Letters | August 27, 2008

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies—Reply

Catherine D. DeAngelis, MD, MPH; Phil B. Fontanarosa, MD, MBA
JAMA. 2008;300(8):900-906. doi:10.1001/jama.300.8.905.
Text Size: A A A
Published online
Article
References

Extract

In Reply: Dr Ferris and colleagues suggest that we incorrectly assumed that he and his coauthors, Dr Kirby and Dr Thal, were “uninvolved ‘guest’ authors ” and is critical that we did not contact him prior to publication of the article by Ross et al.1 However, had we contacted Ferris for such clarification, the available evidence would have confirmed our concerns. Although Ferris, Kirby, and Thal apparently were involved with various aspects of the Merck Rofecoxib 078 study, including reportedly assisting with study design, enrolling patients, and serving on the end point adjudication committee, it appears that these individuals had limited involvement as authors responsible for the manuscript.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Letters

Submit a Letter
August 27, 2008
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
Kent R. Johnson, MD; Marissa N. D. Lassere, MBBS, PhD
JAMA. 2008;300(8):900-906. doi:10.1001/jama.300.8.900-a.
August 27, 2008
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
Garret A. FitzGerald, MD
JAMA. 2008;300(8):900-906. doi:10.1001/jama.300.8.900-b.
August 27, 2008
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
Carlo Patrono, MD
JAMA. 2008;300(8):900-906. doi:10.1001/jama.300.8.901-a.
August 27, 2008
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
Christopher J. Hawkey, DM
JAMA. 2008;300(8):900-906. doi:10.1001/jama.300.8.901-b.
August 27, 2008
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
Steven Ferris, PhD; Douglas Galasko, MD; Louis Kirby, MD
JAMA. 2008;300(8):900-906. doi:10.1001/jama.300.8.901-c.
August 27, 2008
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
Richard Balon, MD
JAMA. 2008;300(8):900-906. doi:10.1001/jama.300.8.902-a.
August 27, 2008
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
Serban-Dan Costa, MD, PhD
JAMA. 2008;300(8):900-906. doi:10.1001/jama.300.8.902-b.
August 27, 2008
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
Hervé Maisonneuve, MD
JAMA. 2008;300(8):900-906. doi:10.1001/jama.300.8.903-a.
August 27, 2008
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
Hean T. Ong, MBBS; Jin S. Cheah, MBBS
JAMA. 2008;300(8):900-906. doi:10.1001/jama.300.8.903-b.
August 27, 2008
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
Peter A. Lachenbruch, PhD; Ronald Wasserstein, PhD
JAMA. 2008;300(8):900-906. doi:10.1001/jama.300.8.904-a.
August 27, 2008
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies—Reply
Bruce M. Psaty, MD, PhD; Richard A. Kronmal, PhD
JAMA. 2008;300(8):900-906. doi:10.1001/jama.300.8.904-b.
August 27, 2008
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies—Reply
Joseph S. Ross, MD, MHS; David S. Egilman, MD, MPH; Harlan M. Krumholz, MD, SM
JAMA. 2008;300(8):900-906. doi:10.1001/jama.300.8.904-c.
CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Clear Answers | Save For Later
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general journals
BMJ 2010;341:c5893-c1494.
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs

More Listings at
JAMACareerCenter.com >

© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems